February 5, 2024 knowmade

Unlock mRNA patent trends and IP insights

Discover the intricacies of mRNA and its rapidly advancing technologies with the assistance of KnowMade’s patent expertise.

  • Gain access to valuable insights on the latest mRNA patent news at no cost.
  • Delve deeper into the field with our comprehensive reports.
  • Stay at the forefront of research and development and intellectual property advancements through our monitoring services.

Insights

Significant rise in mRNA technology intellectual property activity: A third quarter of innovation observed in 2024
SOPHIA ANTIPOLIS, France – October 09, 2024 │ Amidst the rapidly evolving landscape of medical biotechnology, especially in the therapeutic RNA sector, groundbreaking advances continue [...]
Featured image of the article Patent Race: The Competition Between BioNTech and Moderna for the mRNA Vaccine Against Monkeypox.
Patent Race: The Competition Between BioNTech and Moderna for the mRNA Vaccine Against Monkeypox
SOPHIA ANTIPOLIS, France – September 03, 2024 │ The last quarterly report for the 2024 Therapeutic mRNA patent monitor is now available! This report covers [...]
Featured image of the article Q2 2024 IP Activity Reveals New Granted Patents in mRNA Delivery and a Newcomer Developing Therapeutic Circular RNA for Pet Vaccination.
Q2 2024 IP Activity Reveals New Granted Patents in mRNA Delivery and a Newcomer Developing Therapeutic Circular RNA for Pet Vaccination
SOPHIA ANTIPOLIS, France – September 03, 2024 │ The quarterly report for the Q2 2024 Therapeutic mRNA patent monitor is now available! This report covers [...]
Featured image of the post Replicate Bioscience unveils promising clinical progress on self-amplifying RNA at ASGCT annual meeting.
Replicate Bioscience unveils promising clinical progress on self-amplifying RNA at ASGCT annual meeting
SOPHIA ANTIPOLIS, France – May 13, 2024 │ KnowMade actively follows therapeutic mRNA news for its Therapeutic mRNA patent monitor service! What’s new today? REPLICATE [...]
Featured image of Q12024 mRNA monitor Press release.
Q1 2024 IP Activity Reveals Growth and Litigation in Key mRNA Market
SOPHIA ANTIPOLIS, France – April 18, 2024 │ The quarterly report for the Q1 2024 Therapeutic mRNA patent monitor is now available! This report covers [...]
Featured image of our press release upon Q4 2023 patent monitor.
Q4 2023 Therapeutic mRNA patent monitor report: IP dynamic overview
SOPHIA ANTIPOLIS, France – January 22, 2024 │ The quarterly report for the Q4 2023 Therapeutic mRNA patent monitor is now available! This report covers [...]

Reports

Featured image of saRNA patent landscape report. mRNA cancer therapeutics patent landscape featured image. Featured image of RNA vaccine patent landscape.
Self-amplifying RNA vaccines Patent Landscape Analysis 2023 mRNA Cancer Therapies Patent Landscape Analysis 2022 RNA vaccine Patent Landscape 2021

Monitor

mRNA patent monitor featured image.
Therapeutic mRNA Patent Monitor